Posts Categorized: Advocacy

AHF Strongly Condemns Violence Against Rohingya in Rakhine State, Myanmar

YANGON, MYANMAR (January 10, 2017) AIDS Healthcare Foundation (AHF) strongly condemns violence against the Rohingya Muslims in Myanmar’s Rakhine State. As a global humanitarian organization, with operations in 39 countries, including Myanmar, we are committed to providing compassionate medical care to all people affected by HIV/AIDS regardless of ethnicity or religious creed. Since August 2017,…

AHF on New 340B Report: ‘Bought and Paid for by Big Drug Companies!’

AHF steps up criticism of Congressional leadership for buying into Pharma’s false narrative on the 340B program—a federally-administered drug discount pricing program that costs the government and taxpayers nothing and allows nonprofits and hospitals to provide more care and services to needy.  340B’s goal is to “… stretch scarce Federal resources as far as possible,…

AHF Blasts New House Committee Report on 340B Drug Discount Program: ‘A Solution in Search of a Problem’

AHF criticizes Congressional leadership for buying into Pharma’s false narrative on the 340B program—a federally-administered drug discount program that costs the government and taxpayers nothing, and works successfully to allow nonprofits and hospitals to provide more care and services to the needy. Prodded by deep-pocketed Big Pharma as part of its relentless attack on the…

Congressman Scott Peters (D-CA) Gets Thanks from Drug Industry for Reckless Bill Gutting Drug Discounts

Peters curries favor with Big Pharma by co-sponsoring a bill (H.R. 4710) that strangles nonprofit hospitals with useless red tape, forcing many to forgo participating in the 340B drug discount program. In return, a drug industry-financed “AstroTurf” advocacy group placed a misleading online ad thanking Peters, falsely stating that he was, “…working to improve the…

‘Shameless’ Gilead Hikes Key AIDS Drug Pricing 6.9% Despite Recent Patent Expiration

As of January 2018, Gilead has raised the price of its HIV/AIDS treatments Truvada, Genvoya and Descovy 6.9%, despite the fact that the patent for tenofovir, a key component of all three treatments, expired in mid-December.  In October, as patent expiration loomed, AHF called on Gilead for a 90% price reduction on its tenofovir-based drugs,…

LA Blade: AHF highlights ‘social justice’ in Rose Parade (VIDEO)

January 2, 2018 by Karen Ocamb The theme of New Year Day’s 129th Rose Parade was “making a difference,” reminding the US and international audience that “there is kindness in humankind,” as Lance Tibbett, president of the 2018 Tournament of Roses, put it in a video message on KTLA. Indeed, as Donald Trump enters his second…

Picketers Denounce U.S. Rep. Scott Peters for Sponsoring Bill to Gut Drug Discounts

On the Friday before Christmas with little public notice or input, Congressman Scott Peters (D-CA, 52nd District)—who has taken more than $100,000 in contributions from the drug and biotech industries while in Congress—introduced H.R. 4710, a bill that will, “… establish a moratorium on the registration of certain new 340B hospitals and associated sites.” Peters’…

World AIDS Day 2017 Recap

This World AIDS Day we saw the relentless vitality of human spirit paving the way to the eventual end of AIDS. Over 30 years ago, people refused to accept that HIV was a fatal illness and today it is treatable, but much more needs to be accomplished. Now, Test & Treat, condom access, and services for…

New AHF Billboards Highlight Troubling Global HIV/AIDS Statistics Ahead of World AIDS Day on Dec. 1st

LOS ANGELES (November 2) In anticipation of World AIDS Day on December 1st, AIDS Healthcare Foundation (AHF) has launched a new billboard outdoor advertising to call attention to the millions of people still affected by HIV/AIDS around the globe today.  Inspired by vintage fuel pump counters, the billboards draw attention to staggering statistics from UNAIDS…

Legislative Update: U.S. House Energy and Commerce Subcommittee on Oversight and Investigations Holds Hearing on 340B Drug Pricing Program

The U.S. House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations held a hearing on Wednesday, October 11 entitled, “Examining how covered entities utilize the 340B drug pricing program.” Speakers called before the committee represented a range of health care providers, including Ryan White Grantees, similar to AIDS Healthcare Foundation. “While the official…